Cargando…
N-glycosylation stabilizes MerTK and promotes hepatocellular carcinoma tumor growth
Despite the evidences of elevated expression of Mer tyrosine kinase (MerTK) in multiple human cancers, mechanisms underlying the oncogenic roles of MerTK in hepatocellular carcinoma (HCC) remains undefined. We explored the functional effects of MerTK and N-Glycosylated MerTK on HCC cell survival and...
Autores principales: | Liu, Yongzhang, Lan, Linhua, Li, Yujie, Lu, Jing, He, Lipeng, Deng, Yao, Fei, Mingming, Lu, Jun-Wan, Shangguan, Fugen, Lu, Ju-Ping, Wang, Jiaxin, Wu, Liang, Huang, Kate, Lu, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214875/ https://www.ncbi.nlm.nih.gov/pubmed/35728303 http://dx.doi.org/10.1016/j.redox.2022.102366 |
Ejemplares similares
-
MerTK inhibition by RXDX-106 in MerTK activated gastric cancer cell lines
por: Kim, Jung Eun, et al.
Publicado: (2017) -
Harnessing MerTK agonism for targeted therapeutics
por: Kedage, Vivekananda, et al.
Publicado: (2019) -
MerTK, a risk factor for NASH fibrosis
por: Wang, Xiaobo, et al.
Publicado: (2020) -
MerTK is required for apoptotic cell–induced T cell tolerance
por: Wallet, Mark A., et al.
Publicado: (2008) -
MerTK is a novel therapeutic target in gastric cancer
por: Yi, Jun Ho, et al.
Publicado: (2015)